Omeros Corporation (NASDAQ: OMER) announced that new research related to the clinical utility of OMIDRIA (phenylephrine and ketorolac injection) 1 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE